Also, the ability of MAPK to trigger the expression of PD-L1 in melanoma cells conferring resistance BRAF inhibitors has been reported [261,262], suggesting that the inhibition of MAPK pathway may overcome MM resistance to immunotherapy. This evidence concerns the gene BRAF and Miyoshi myopathy.